Board of Directors

If you are interested in becoming a member of the Board of Psychedelic Medicine and Therapies Board of Directors, please visit our Become a Board of Director page for full details about the role and commitment. If you would like to apply for the Board of Directors’, please apply at BPMT Board of Directors Application.


NiCole T. Buchanan, PhD

Interim Board Chair and CEO

NiCole T. Buchanan, PhD, is a professor at Michigan State University and Clinical Director and Founder of Alliance Psychological Associates, PPLC. She is the Interim Board Chair and CEO of the Board of Psychedelic Medicine and Therapies (BPMT), serves on the Board of Directors and the Racial Equity and Access Committee of the Chacruna Institute for Psychedelic Plant Medicine and previously served as the Co-Chair of the Inaugural Board of Directors for the American Psychedelic Practitioners Association (APPA).

Dr. Buchanan trained with MAPS’ MDMA-assisted therapy, Polaris Insight Center’s Ketamine-Assisted Psychotherapy training and the California Institute of Integral Studies’ Certificate for Psychedelic Research and Therapy. She is a Fellow of the Association for Psychological Science and four divisions of the American Psychological Association and has received international awards for her contributions to the field. An accomplished consultant, speaker, writer, and scholar, she has over 120 publications focusing on equity and inclusion (in psychedelics, clinical training, and organizations), harassment, organizational climate, employee wellbeing, and professional development. Her work is highlighted in hundreds of media outlets and she is a featured international speaker, including at TEDx and on National Public Radio.

See for a list of Dr. Buchanan’s publications.

Sean McAllister

Sean McAllister

Board of Director

Sean T. McAllister is an attorney specializing in the regulatory, business, and religious freedom aspects of psychedelic medicines and therapies. His work in psychedelics has included: Advising doctors, therapists and licensed professional on psychedelic assisted therapy; Advising clients on what is allowed in cities that have decriminalized psychedelics; Advising clients looking to obtain a religious exemption from criminal law for the use of psychedelics under the Religious Freedom Restoration Act; Seeking DEA licensure for companies to manufacture Schedule I drugs lawfully in the United States; Steering committee member on Colorado’s Proposition 122 Natural Medicine Health Act; Executive Officer of the Denver Psilocybin Mushroom Policy Review Panel; Co-counsel for Church of the Eagle and the Condor in a lawsuit against DEA to gain recognition as an ayahuasca church; General Counsel for of the non-profit organization Zendo Project Inc.; Chair of the Board of Directors for the Chacruna Institute for Psychedelic Plant Medicines; and Board of Directors of the Board of Psychedelic Medicine and Therapies. Sean is licensed to practice law in Colorado and California.